Aether Industries Valuation
Is AETHER undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of AETHER when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von AETHER für die Bewertungsanalyse.
Deutlich unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von AETHER für die Bewertungsanalyse.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AETHER?
Other financial metrics that can be useful for relative valuation.
What is AETHER's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₹111.92b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 16.5x |
Enterprise Value/EBITDA | 63x |
PEG Ratio | 2.3x |
Price to Earnings Ratio vs Peers
How does AETHER's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 24.8x | ||
532482 Granules India | 27.8x | 25.1% | ₹107.7b |
524742 Caplin Point Laboratories | 22.2x | 11.0% | ₹99.0b |
ERIS Eris Lifesciences | 30x | 15.9% | ₹114.2b |
GLS Glenmark Life Sciences | 19.3x | 11.2% | ₹100.1b |
AETHER Aether Industries | 92.1x | 40.5% | ₹112.7b |
Price-To-Earnings gegen Gleichaltrige: AETHER ist auf der Grundlage des Price-To-Earnings Verhältnisses (93.9x) im Vergleich zum Durchschnitt der Vergleichsgruppe (45.8x) teuer.
Price to Earnings Ratio vs Industry
How does AETHER's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?
Price-To-Earnings gegen Industrie: AETHER ist teuer, wenn man sein Price-To-Earnings Verhältnis (93.9x) mit dem Indian Pharmaceuticals Branchendurchschnitt (34.9x) vergleicht.
Price to Earnings Ratio vs Fair Ratio
What is AETHER's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 92.1x |
Fair PE Ratio | 43.9x |
PM vs. Fair Ratio: AETHER ist teuer auf der Grundlage des Verhältnisses Price-To-Earnings (93.9x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Earnings (46.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | ₹844.35 | ₹1,069.67 +26.7% | 3.5% | ₹1,120.00 | ₹1,029.00 | n/a | 3 |
Mar ’25 | ₹869.60 | ₹1,069.67 +23.0% | 3.5% | ₹1,120.00 | ₹1,029.00 | n/a | 3 |
Feb ’25 | ₹866.05 | ₹1,090.00 +25.9% | 2.8% | ₹1,120.00 | ₹1,060.00 | n/a | 2 |
Jan ’25 | ₹882.45 | ₹1,095.00 +24.1% | 3.2% | ₹1,130.00 | ₹1,060.00 | n/a | 2 |
Dec ’24 | ₹794.85 | ₹1,095.00 +37.8% | 3.2% | ₹1,130.00 | ₹1,060.00 | n/a | 2 |
Nov ’24 | ₹870.05 | ₹1,095.00 +25.9% | 3.2% | ₹1,130.00 | ₹1,060.00 | n/a | 2 |
Oct ’24 | ₹968.45 | ₹1,085.00 +12.0% | 2.3% | ₹1,110.00 | ₹1,060.00 | n/a | 2 |
Sep ’24 | ₹990.75 | ₹1,085.00 +9.5% | 2.3% | ₹1,110.00 | ₹1,060.00 | n/a | 2 |
Aug ’24 | ₹1,093.25 | ₹1,085.00 -0.8% | 2.3% | ₹1,110.00 | ₹1,060.00 | n/a | 2 |
Jul ’24 | ₹1,067.90 | ₹1,070.00 +0.2% | 0.9% | ₹1,080.00 | ₹1,060.00 | n/a | 2 |
Feb ’24 | ₹879.10 | ₹892.50 +1.5% | 18.8% | ₹1,060.00 | ₹725.00 | ₹866.05 | 2 |
Jan ’24 | ₹839.15 | ₹892.50 +6.4% | 18.8% | ₹1,060.00 | ₹725.00 | ₹882.45 | 2 |
Dec ’23 | ₹908.85 | ₹892.50 -1.8% | 18.8% | ₹1,060.00 | ₹725.00 | ₹794.85 | 2 |
Analysten-Prognose: Das Kursziel liegt mehr als 20% über dem aktuellen Aktienkurs, und die Analysten liegen in einem statistisch sicheren Bereich der Übereinstimmung.